Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Journal of Immunological Methods
|
October 15, 2022
Generation of good manufacturing practice grade virus-specific T cells for the management of post-transplant CMV infections
Arun Kumar Arunachalam, Hamenth Kumar Palani, Mohammed Yasar, et al.
Molecular Cancer Research : MCR
|
January 10, 2020
Combination Lenalidomide/Bortezomib Treatment Synergistically Induces Calpain-Dependent Ikaros Cleavage and Apoptosis in Myeloma Cells
Saravanan Ganesan, Hamenth Kumar Palani, Nithya Balasundaram, et al.
Scientific Reports
|
April 10, 2024
Ablation of Wnt signaling in bone marrow stromal cells overcomes microenvironment-mediated drug resistance in acute myeloid leukemia
Hamenth Kumar Palani, Saravanan Ganesan, Nithya Balasundaram, et al.
Cell Death & Disease
|
October 2, 2019
Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia
Saravanan Ganesan, Hamenth Kumar Palani, Vairavan Lakshmanan, et al.
Cell Transplantation
|
September 14, 2023
Haploidentical Natural Killer Cell Therapy as an Adjunct to Stem Cell Transplantation for Treatment of Refractory Acute Myeloid Leukemia
Uday Kulkarni, Arun Kumar Arunachalam, Hamenth Kumar Palani, et al.
Bone Marrow Transplantation
|
November 8, 2022
Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience and cost analysis in India
Hamenth Kumar Palani, Arun Kumar Arunachalam, Mohammed Yasar, et al.
Blood Advances
|
October 9, 2021
Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia
Nithya Balasundaram, Saravanan Ganesan, Ezhilarasi Chendamarai, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
November 15, 2018
Prevalence of FVIII inhibitors in severe haemophilia A patients: Effect of treatment and genetic factors in an Indian population
Sachin David, Sukesh C Nair, G Surender Singh, et al.
Cell Death & Disease
|
November 4, 2025
A novel strategy to target metabolic dependencies in acute myeloid leukemia
Nithya Balasundaram, Hamenth Kumar Palani, Arvind Venkatraman, et al.
Molecular Therapy. Oncology
|
April 18, 2025
Safety, efficacy and total cost of point-of-care manufactured anti-CD19 CAR-T cell therapy in India: VELCART trial
Hamenth Kumar Palani, Arun Kumar Arunachalam, Uday Kulkarni, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Journal of Immunological Methods
|
October 15, 2022
Generation of good manufacturing practice grade virus-specific T cells for the management of post-transplant CMV infections
Arun Kumar Arunachalam, Hamenth Kumar Palani, Mohammed Yasar, et al.
Molecular Cancer Research : MCR
|
January 10, 2020
Combination Lenalidomide/Bortezomib Treatment Synergistically Induces Calpain-Dependent Ikaros Cleavage and Apoptosis in Myeloma Cells
Saravanan Ganesan, Hamenth Kumar Palani, Nithya Balasundaram, et al.
Scientific Reports
|
April 10, 2024
Ablation of Wnt signaling in bone marrow stromal cells overcomes microenvironment-mediated drug resistance in acute myeloid leukemia
Hamenth Kumar Palani, Saravanan Ganesan, Nithya Balasundaram, et al.
Cell Death & Disease
|
October 2, 2019
Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia
Saravanan Ganesan, Hamenth Kumar Palani, Vairavan Lakshmanan, et al.
Cell Transplantation
|
September 14, 2023
Haploidentical Natural Killer Cell Therapy as an Adjunct to Stem Cell Transplantation for Treatment of Refractory Acute Myeloid Leukemia
Uday Kulkarni, Arun Kumar Arunachalam, Hamenth Kumar Palani, et al.
Bone Marrow Transplantation
|
November 8, 2022
Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience and cost analysis in India
Hamenth Kumar Palani, Arun Kumar Arunachalam, Mohammed Yasar, et al.
Blood Advances
|
October 9, 2021
Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia
Nithya Balasundaram, Saravanan Ganesan, Ezhilarasi Chendamarai, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
November 15, 2018
Prevalence of FVIII inhibitors in severe haemophilia A patients: Effect of treatment and genetic factors in an Indian population
Sachin David, Sukesh C Nair, G Surender Singh, et al.
Cell Death & Disease
|
November 4, 2025
A novel strategy to target metabolic dependencies in acute myeloid leukemia
Nithya Balasundaram, Hamenth Kumar Palani, Arvind Venkatraman, et al.
Molecular Therapy. Oncology
|
April 18, 2025
Safety, efficacy and total cost of point-of-care manufactured anti-CD19 CAR-T cell therapy in India: VELCART trial
Hamenth Kumar Palani, Arun Kumar Arunachalam, Uday Kulkarni, et al.
Page
of 2